← All organizations
First clinical trial
May 30, 2017Last known activity
Dec 31, 2022
Acquired by Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio → Frequency Therapeutics → Korro Bio on Jul 14, 2023
Timeline
Drugs by trial phase (3 distinct, 8 trials)
Indications
Subsidiaries (1 direct, 25 total across the full acquisition tree)
- Korro Bio
- Frequency Therapeutics L2
- Korro Bio L3
- Frequency Therapeutics L4
- Korro Bio L5
- Frequency Therapeutics L6
- Korro Bio L7
- Frequency Therapeutics L8
- Korro Bio L9
- Frequency Therapeutics L10
- Korro Bio L11
- Frequency Therapeutics L12
- Korro Bio L13
- Frequency Therapeutics L14
- Korro Bio L15
- Frequency Therapeutics L16
- Korro Bio L17
- Frequency Therapeutics L18
- Korro Bio L19
- Frequency Therapeutics L20
- Korro Bio L21
- Frequency Therapeutics L22
- Korro Bio L23
- Frequency Therapeutics L24
- Korro Bio L25
Recent trials (12)
- NCT05664100Lead sponsorPhase 1Dec 31, 2022
- NCT05664100Study directorPhase 1Dec 31, 2022
- NCT05086276Lead sponsorPhase 2Oct 12, 2021
- NCT05086276Study directorPhase 2Oct 12, 2021
- NCT04629664Study directorPhase 1Nov 2, 2020
- NCT04629664Lead sponsorPhase 1Nov 2, 2020
- NCT04601909Study directorPhase 1Sep 17, 2020
- NCT04601909Lead sponsorPhase 1Sep 17, 2020
- NCT04120116Lead sponsorPhase 2Oct 4, 2019
- NCT04120116Study directorPhase 2Oct 4, 2019
- NCT03616223Lead sponsorPhase 1/Phase 2Jul 3, 2018
- NCT03300687Lead sponsorEarly Phase 1May 30, 2017
Details
- Founded
- Woburn, MA, US Jun 1, 2015
- Last known activity
- Dec 31, 2022